🔎 Trials Near Me

Home › Neuroblastoma › Ohio › Cincinnati

Pag-aaral pangklinika para sa Neuroblastoma sa Cincinnati, OH

9 pag-aaral para sa Neuroblastoma ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Cincinnati (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

Resource Intervention to Support Equity (RISE) in High-Risk Neuroblastoma

Nagre-recruit
  • Cincinnati Children's Hospital Medical Center, Cincinnati
Hanggang edad 17 · Lahat ng kasarian · Na-update Nob 13, 2026 · NCT06831552

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

Nagre-recruitPhase 3
  • Cincinnati Children's Hospital Medical Center, Cincinnati
Hanggang edad 30 · Lahat ng kasarian · Na-update Okt 30, 2026 · NCT06172296

Phase 1 Dose-escalating Study of MM-398 (Irinotecan Sucrosofate Liposome Injection) Plus Intravenous Cyclophosphamide in Recurrent or Refractory Pediatric Solid Tumors

Nagre-recruitPhase 1
  • Cincinnati Children's Hospital Medical Center, Cincinnati
12 Months – 20 Years · Lahat ng kasarian · Na-update Okt 8, 2026 · NCT02013336

Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

Nagre-recruitPhase 3
  • Cincinnati Children's Hospital Medical Center, Cincinnati
365 Days – 30 Years · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT03126916

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

Nagre-recruitPhase 1/2
  • Cincinnati Children's Hospital Medical Center, Cincinnati
12 Months – 30 Years · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT04851119

Haploidentical Donor Cytokine-Induced Memory-Like Natural Killer Cells (CIML-NK) for Relapsed & Refractory Neuroblastoma

Nagre-recruitPhase 2
  • Cincinnati Children's Hospital Medical Center, Cincinnati
Edad 1 hanggang 39 · Lahat ng kasarian · Na-update Ago 24, 2026 · NCT07635056

SPEARHEAD-3 Pediatric Study

Nagre-recruitPhase 1/2
  • Cincinnati Children's Hospital Medical Center, Cincinnati
Edad 2 hanggang 21 · Lahat ng kasarian · Na-update Ago 11, 2026 · NCT05642455

NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) Trial

Nagre-recruitPhase 2
  • Cincinnati Children's Hospital Medical Center, Cincinnati
Edad 1 hanggang 31 · Lahat ng kasarian · Na-update Hul 20, 2026 · NCT06450041

Neuroblastoma Biology Study

Nagre-recruitObservasyonal na pag-aaral
  • Cincinnati Children's Hospital Medical Center, Cincinnati
31 Days – 99 Years · Lahat ng kasarian · Na-update Mar 23, 2026 · NCT01587300

Pag-aaral para sa Neuroblastoma sa ibang lungsod

Iba pang pag-aaral sa Cincinnati

Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.